| covid 19 nih treatment guidelines | 1.96 | 1 | 7218 | 33 | 44 |
| covid 19 nih treatment guidelines paxlovid | 0.11 | 0.7 | 4115 | 42 | 37 |
| nih covid 19 treatment guidelines panel | 0.3 | 0.5 | 197 | 39 | 29 |
| covid 19 treatment guideline 2022 nih | 0.68 | 0.3 | 3610 | 37 | 96 |
| covid treatment guidelines paxlovid | 1.45 | 0.7 | 6199 | 35 | 30 |
| paxlovid treatment for covid 19 | 0.03 | 0.5 | 266 | 31 | 87 |
| covid 19 treatment guidelines nih | 0.69 | 0.7 | 7552 | 33 | 62 |
| covid 19 treatments drugs paxlovid | 1.26 | 0.1 | 7809 | 34 | 32 |
| cdc covid guidelines paxlovid | 0.27 | 0.7 | 255 | 29 | 64 |
| covid 19 paxlovid indications | 0.49 | 0.6 | 9680 | 29 | 37 |
| medicine for covid 19 paxlovid | 0.24 | 0.7 | 2378 | 30 | 17 |
| how does paxlovid treat covid 19 | 0.01 | 0.4 | 8443 | 32 | 58 |
| covid 19 paxlovid dose | 1.87 | 0.3 | 78 | 22 | 97 |
| covid 19 and paxlovid | 1.38 | 0.9 | 7035 | 21 | 88 |
| cdc recommendations for covid and paxlovid | 1.12 | 0.5 | 4710 | 42 | 43 |
